Trade Novartis - CHF - NOVN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.55 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.011506% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.010716% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 98.05 |
| Open | 98.5 |
| 1-Year Change | 13.81% |
| Day's Range | 97.9 - 98.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 98.45 | 0.40 | 0.41% | 98.05 | 98.85 | 96.45 |
| Mar 27, 2025 | 98.05 | 0.75 | 0.77% | 97.30 | 98.45 | 96.35 |
| Mar 26, 2025 | 94.90 | -2.35 | -2.42% | 97.25 | 97.45 | 94.90 |
| Mar 25, 2025 | 97.95 | -0.30 | -0.31% | 98.25 | 99.15 | 96.65 |
| Mar 24, 2025 | 98.45 | -0.50 | -0.51% | 98.95 | 99.20 | 96.75 |
| Mar 21, 2025 | 99.55 | 1.00 | 1.01% | 98.55 | 99.85 | 97.45 |
| Mar 20, 2025 | 97.60 | 0.30 | 0.31% | 97.30 | 99.80 | 97.30 |
| Mar 19, 2025 | 98.25 | 0.65 | 0.67% | 97.60 | 98.55 | 96.15 |
| Mar 18, 2025 | 98.10 | -0.35 | -0.36% | 98.45 | 98.70 | 96.65 |
| Mar 17, 2025 | 96.55 | 0.45 | 0.47% | 96.10 | 98.45 | 95.50 |
| Mar 14, 2025 | 96.30 | -0.15 | -0.16% | 96.45 | 96.65 | 93.65 |
| Mar 13, 2025 | 96.80 | 1.00 | 1.04% | 95.80 | 97.35 | 94.45 |
| Mar 12, 2025 | 96.10 | 0.65 | 0.68% | 95.45 | 97.05 | 94.90 |
| Mar 11, 2025 | 95.35 | -3.00 | -3.05% | 98.35 | 98.80 | 94.05 |
| Mar 10, 2025 | 101.40 | 0.35 | 0.35% | 101.05 | 101.70 | 99.75 |
| Mar 7, 2025 | 100.85 | 2.45 | 2.49% | 98.40 | 100.95 | 98.15 |
| Mar 6, 2025 | 97.80 | -0.75 | -0.76% | 98.55 | 99.70 | 96.95 |
| Mar 5, 2025 | 99.85 | 0.95 | 0.96% | 98.90 | 100.05 | 98.00 |
| Mar 4, 2025 | 99.25 | 0.45 | 0.46% | 98.80 | 99.80 | 97.45 |
| Mar 3, 2025 | 98.85 | 1.10 | 1.13% | 97.75 | 98.95 | 96.00 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Novartis - CHF Company profile
Novartis AG (NVS) is a global pharmaceutical company. Founded in 1996 through a merger of Ciba-Geigy and Sandoz, Novartis is headquartered in Basel, Switzerland. The firm has two divisions: Innovative Medicines and Sandoz.
Innovative Medicines offer prescription medicines and create treatments in areas of respiratory, ophthalmology, neuroscience, immunology, hepatology, dermatology, cardiovascular, renal and metabolism.
Sandoz develops, manufactures and markets generic pharmaceuticals and biosimilars. Sandoz products include: Adakveo (crizanlizumab), Afinitor Disperz/Votubia (everolimus) and Arzerra (ofatumumab) for Oncology; and Aimovig (erenumab) for neuroscience.
In 2020, in response to the pandemic, the company collaborated with Molecular Partners to develop ensovibep, a DARPin therapeutic candidate designed for potential use against Covid-19.
The company’s shares have been listed on the New York Stock Exchange (NYSE) since 2000. Novartis AG stock is traded under the ticker symbol NVS. You can track live NVS share value and price history at Capital.com.
| Industry: | Pharmaceuticals (NEC) |
Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com